1887

Abstract

An immunodominant Epstein—Barr virus (EBV)-specific cytotoxic T lymphocyte (CTL) epitope, represented by peptide 68, has been mapped to the EBV nuclear antigen, EBNA 3. The epitope is recognized by class I-restricted CTLs through HLA-B8 and is functionally active on type A but not type B lymphoblastoid cell lines (LCLs). Herein we show that peptide 68 is not expressed as a functional CTL epitope by type A LCLs infected with an EBV B95-8 isolate. CTLs from cultures stimulated with autologous type A IARC-BL74 or QIMR-WIL LCLs lysed autologous cells stimulated with phytohaemagglutinin (PHA blasts) and coated with exogenous peptide 68. No peptide 68-specific CTLs were generated in cultures stimulated with autologous type A B95-8 or type B AG876 LCLs. However, the B95-8 LCL coated with peptide 68 was effective in the induction of a peptide-specific CTL response. A peptide 68-specific CTL clone failed to lyse the B95-8 LCL, type B AG876 LCL and PHA blasts, although such targets were lysed when coated with peptide 68.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-2-405
1991-02-01
2021-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/2/JV0720020405.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-2-405&mimeType=html&fmt=ahah

References

  1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Séguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95–8 Epstein-Barr virus genome. Nature, London 310:207–211
    [Google Scholar]
  2. Bastin J., Rothbard J., Davey J., Jones I., Townsend A. 1987; Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. Journal of Experimental Medicine 165:1508–1523
    [Google Scholar]
  3. Burrows S. R., Sculley T. B., Misko I. S., Schmidt C., Moss D. J. 1990a; An Epstein-Barr virus-specific cytotoxic T cell epitope in EBNA 3. Journal of Experimental Medicine 171:345–349
    [Google Scholar]
  4. Burrows S. R., Misko I. S., Sculley T. B., Schmidt C., Moss D. J. 1990b; An Epstein–Barr-virus specific T cell epitope present on A- and B-type transformants. Journal of Virology 64:3974–3976
    [Google Scholar]
  5. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. 1984; U2 region of Epstein Barr virus DNA may encode Epstein-Barr nuclear antigen. Proceedings of the National Academy of Sciences, U,. S,. A 81:7632–7636
    [Google Scholar]
  6. DeLisi C., Berzofsky J. A. 1985; T-cell antigenic sites tend to be amphipathic structures. Proceedings of the National Academy of Sciences, U,. S,. A 82:7048–7052
    [Google Scholar]
  7. Del Val M., Munch K., Reddehase M. J., Koszinowski U. H. 1989; Presentation of CMV immediate-early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase. Cell 58:305–315
    [Google Scholar]
  8. Houghten R. A. 19851; General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.. Proceedings of the National Academy of Sciences, U,. S,. A. 82:5131–5135
    [Google Scholar]
  9. Joly E., Salvato M., Whitton J. L., Oldstone M. B. A. 1989; Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein. Journal of Virology 63:1845–1851
    [Google Scholar]
  10. Klein G. 1989; Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58:5–8
    [Google Scholar]
  11. Masucci M., Torsteinsdottir S., Colombani J., Brautbar C., Klein E., Klein G. 1987; Down-regulation of class I HLA antigens and of Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proceedings of the National Academy of Sciences, U,. S,. A 84:4567–4571
    [Google Scholar]
  12. Miller G., Lipman M. 1973; Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, U,. S,. A 70:190–194
    [Google Scholar]
  13. Misko I. S., Moss D. J., Pope J. H. 1980; HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proceedings of the National Academy of Sciences, U,. S,. A 77:4247–4250
    [Google Scholar]
  14. Misko I. S., Pope J. H., Hutter R., Soszynski T. D., Kane R. G. 1984; HLA-DR-antigen-associated restriction of EBV-specific T-cell colonies. International Journal of Cancer 33:239–243
    [Google Scholar]
  15. Moss D. J., Rickinson A. B., Pope J. H. 1978; Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. International Journal of Cancer 22:662–668
    [Google Scholar]
  16. Moss D. J., Misko I. S., Burrows S. R., Burman K., McCarthy R., Sculley T. B. 1988; Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature, London 331:719–721
    [Google Scholar]
  17. Petti L., Kieff E. 1988; A sixth Epstein-Barr virus nuclear protein (EBNA 3B) is expressed in latently infected growth transformed lymphocytes. Journal of Virology 62:2173–2178
    [Google Scholar]
  18. Pope J. H., Horne M. K., Scott W. 1968; Transformation of foetal human leukocytes in vitro by infiltrates of a human leukemia cell line containing herpes-like virus. Internationa Journal of Cancer 3:857–866
    [Google Scholar]
  19. Rickinson A. B., Moss D. J., Wallace L. E., Rowe M., Misko I. S., Epstein M. A., Pope J. H. 1981; Long-term cell-mediated immunity to Epstein-Barr virus. Cancer Research 41:4216–4221
    [Google Scholar]
  20. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 7:93–100
    [Google Scholar]
  21. Rowe M., Young L. S., Cadwallader K., Petti L., Kieff E., Rickinson A. B. 1989; Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. Journal of Virology 63:1031–1039
    [Google Scholar]
  22. Sculley T. B., Apollini A., Stumm R., Moss D. J., Mueller-Lantcsh N., Misko I. S., Cooper D. A. 1989; Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology 171:401–408
    [Google Scholar]
  23. Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. 1989; Detection of a second widespread strain of Epstein-Barr virus. Lancet ii:761–765
    [Google Scholar]
  24. Takahashi H., Merli S., Putney S. D., Houghten R., Moss B., Germain R. N., Berzofsky J. A. 1989; A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gpl60. Science 246:118–121
    [Google Scholar]
  25. Townsend A., Bodmer H. 1989; Antigen recognition by class I-restricted T lymphocytes. Annual Review of Immunology 7:601–624
    [Google Scholar]
  26. Zimber U., Adldinger H. K., Lenoir G. M., Vuillaume M., Knebel-Doeberitz M. V., Laux G., Desgranges C., Wittmann P., Freese U.-K., Schneider U., Bornkamm G. W. 1986; Geographical prevalence of two types of Epsein-Barr virus. Virology 154:56–66
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-2-405
Loading
/content/journal/jgv/10.1099/0022-1317-72-2-405
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error